Epidemiology
Few studies have been reported on the population based incidence and prevalence, mode of presentation, immunopathologic features, pattern of steroid response and the long term prognosis of IgMN in either children or adults (Myllymaki et al., 1993) . Most of the studies have reported the prevalence of the disease as frequency or percentage of renal biopsies with a diagnosis of IgMN. The frequency of IgMN reported in literature has varied considerably from 2% to 18.5% (Al-Eisa et al., 1996; Cavalo et al., 1981; Kazi et al., 2010; Kopolovic et al., 1987; Lawler et al., 1980; Mampaso et al., 1981; Cavalo & Johnson, 1981; Chan et al., 2000; Donia et al., 2000; Hsu et al., 1984; Jungthirapanich et al., 1997; Kobayashi et al., 1982; Mubarak et al., 2011; Singhai et al., 2011; Tejani & Nicastri, 1983 ). The first two pioneering studies found frequencies of 2 and 6.1% respectively in their biopsy series (Cohen et al., 1978; Bhasin et al., 1978) . Soon thereafter, a frequency of 11.7% of IgMN was reported in a study by Lawler et al. from UK (1980) . Hsu et al. (1984) found a frequency of 10% of IgMN in all biopsies with primary glomerular disease. One of the largest and long-term longitudinal series on IgMN has come from Finland, comprising of 110 patients, including both adults and children (Myllimaki et al., 2003) . More recently, we have published our experience in the largest study ever carried out on 135 children with INS and IgMN as the biopsy diagnosis (Mubarak et al., 2011) . The exact cause for this wide variation in the prevalence of IgMN is unclear but may be partly due to varying biopsy indications, varying criteria for the diagnosis of this lesion used in different studies, and partly to genetic or environmental factors. Most of the studies have been undertaken on native renal biopsies; however, occasional cases of its occurrence in renal transplant recipients have also been reported (Salmon AH et al., 2004) .
Etiology
As with IgAN, the etiology of this common form of primary GN is still largely unknown. IgM deposits in the glomeruli may be seen in a variety of systemic diseases, such as systemic lupus erythematosus (SLE), rheumatoid arthritis, diabetes mellitus, Alport's syndrome, and paraproteinemia. For a diagnosis of primary IgMN, the above conditions must be excluded.
Pathogenesis
As with the etiology, the pathogenesis of this disease is also still elusive. Very few studies have been undertaken on the pathogenesis of this condition, mainly because this disease is not accepted widely as a distinct entity in most of the western countries (Border, 1988) . Some investigators have suggested classical immune complex mediated activation of complement system leading to mesangial injury and reaction (Hsu et al., 1984) . They cite as evidence the presence of C1q and C4 deposits along with IgM in glomerular mesangium in majority of cases, while properdin and factor B were not found (Hsu et al., 1984) . Others have found C3 in majority of cases and C1q only infrequently (Mubarak et al., 2011) . The source of antigens triggering immune complex formation is not known, but it is hypothesized that certain antigens in the food or environment which preferentially elicit IgM response may be responsible. Abnormalities of T-lymphocyte function or a disturbance in immune complex clearance by mesangial cells have also been suggested (Hsu et al., 1984) . Many studies have found increased serum IgM or IgM immune complex concentrations in patients with IgMN (Disciullo et al., 1988; Hsu et al., 1984) . No abnormalities of IgM molecule, as are observed in IgA, have been detected or reported as yet. Similarly, no animal studies have been conducted on this disease till now.
Pathology
The diagnosis of IgMN requires, like IgAN, examination of renal biopsy by at least LM and IF methods. EM is not essential but optional and often confirms the findings seen on LM and IF. The pathologic findings are correlated with clinical and serological studies to diagnose the primary form of the disease.
Light microscopy
The LM findings in IgMN are heterogeneous, as in IgAN. The spectrum of changes is however not as wide as in IgAN and includes minor changes, variable degree of mesangial proliferation, usually of mild to moderate degree, and FSGS (Mubarak et al., 2011; Myllimaki et al., 2003) (Fig. 1, 2 ). Many biopsies also display small cellular crescents (Lawler et al., 1980; Kishimoto & Arakawa, 1999) . The most common morphologic change reported consists of mesangial proliferation of the glomeruli, mostly of mild to moderate degree (Hsu et al., 1984) . In a minority of cases, severe mesangial proliferation with interpositioning of the expanded mesangium into the peripheral capillary walls with consequent splitting and tram-track appearance have also been noted (Kishimoto & Arakawa, 1999) . Minor changes on LM are reported in about one third of cases (Hsu et al., 1984; Mubarak et al., 2011; Myllimaki et al., 2003) . FSGS morphology is also commonly reported in IgMN. These cases show diffuse mesangial positivity of IgM in contrast to nonspecific, segmental trapping of IgM in idiopathic FSGS. The previously reported prevalence of this morphologic pattern in biopsies of IgMN shows wide variation (Lawler et al., 1980; Mubarak et al., 2011; Myllimaki et al., 2003) . Some investigators have entirely excluded this lesion in their study patients; others have included those cases of FSGS showing diffuse mesangial positivity of IgM in the category of IgMN, as in our study (Mubarak et al., 2011) . The reported rates of this lesion have varied from 9 to 65.2% (Mubarak et al., 2011; Myllimaki et al., 2003) . This pattern was also noted in one third of the cases in our study (Mubarak et al., 2011) . Still other investigators have reported progression of IgMN cases with minor changes or mesangial proliferation into FSGS on repeat biopsies (Myllimaki et al., 2003; Zeis et al., 2001) . We have observed one case each of florid crescentic GN and a case of collapsing FSGS as a morphologic expression of IgMN (unpublished data). Tubular atrophy and interstitial scarring are also commonly observed on renal biopsies of IgMN at the time of diagnosis and are usually mild (Mubarak et al., 2011; Myllimaki et al., 2003) . Moderate and severe tubular atrophy have been rarely reported. Mild fibrointimal thickening of arteries has also been reported in a minority of cases (Mubarak et al., 2011) .
Immunoflourescence
Like IgAN, IgMN is a diagnosis of IF microscopy. Characteristic of the disease is a diffuse and global mesangial positivity of IgM (either as sole immunogloblulin or predominant) of at least 1+ intensity on a scale of 0-3+ (where 0 is absent, 1+ is mild, 2+ is moderate, and 3+ is marked) (Mubarak et al., 2011; Myllimaki et al., 2003) (Fig. 3) . Some studies have included trace positivity of IgM on IF as IgMN. Concomitant but not dominant deposits of IgA and IgG are found in a small percentage of cases (Mubarak et al., 2011; Myllimaki et al., 2003) . Complement fragments of C3 and C1q are found in majority of cases co-localized with IgM deposits (Mubarak et al., 2011; Myllimaki et al., 2003; Zeis et al., 2001 ).
Electron microscopy
There are very few studies on the ultrastructural features of IgMN. In majority of cases, no EM was done and the diagnosis was made solely on IF microscopy. The few studies that have carried out EM examination have noted small, granular to short linear, electron-dense deposits in the mesangium and paramesangium, along with variable degrees of mesangial cell proliferation and mesangial matrix expansion. Variable degrees of fusion of foot processes commensurate with the degree of proteinuria have also been observed. The electron-dense deposits have typically been of low volume and low density, and in many cases, rather ill-defined (Al- Eisa et al., 1996; Hsu et al., 1984; Myllimaki et al., 2003) . 
Clinical manifestations
Clinically, the disease most commonly presents with INS in both children and adults. The disease also frequently presents with hematuria (HU) or asymptomatic urinary abnormalities (AUA). However, in many centers of the world, patients with the later manifestations are not subjected to renal biopsy, which accounts for the low number of patients presenting with these manifestations. It is believed that patients with HU, especially adult females, have a good prognosis, as compared with patients with NS or proteinuria (PU) (Myllimaki et al., 2003) . Hypertension is frequent at presentation or biopsy, being found in roughly one third of cases. Its prevalence increases with increasing duration of the disease approaching 50% at 15 years of follow-up (Myllimaki et al., 2003) . The disease predominantly affects males as compared with females. Some studies have found a female preponderance, especially in those patients presenting with HU. Isolated HU or proteinuria-hematuria (PU-HU) have constituted almost half of biopsy indications in some previous reports (Myllimaki et al., 2003) . This may have implications for the severity of the pathological lesions observed on renal biopsy and the long term outcome of disease. It has been observed, however, that IgMN in children mostly presents as INS rather than as HU or PU, as shown in the study by Myllimaki et al. (2003) , in which 32 of 36 children with IgMN presented as NS and only four children presented with non nephrotic proteinuria and none presented with PU-HU or HU. 
Treatment
IgMN is treated in the same manner as MCD or FSGS. Corticosteroids form the mainstay of treatment. Similar to its prevalence, the steroid response pattern in IgMN varies considerably; steroid resistance reported varies from 0 to 52% (Border, 1988) . We found a steroid resistance pattern in about one third of our children presenting with INS. Border (1988) . also found a mean of 28% steroid resistance on a review of nine published studies of IgMN (Border, 1988) . It follows from these studies that IgMN responds less well to steroids compared to typical minimal change disease (MCD), and favors the hypothesis that IgMN is distinct from MCD (Mubarak et al., 2011; Myllimaki et al., 2003) . Other researchers have not found any significant differences in clinical, pathological or steroid response pattern among these diseases (Al-Eisa et al., 1996; Ji-Yun et al., 1984) .
Clinical course and prognosis
The clinical course and prognosis of IgMN are also very variable. Part of the variation in the studies is due to variable length of follow-up of the patients and variable case definitions. In the largest and longest follow-up study from Finland, renal insufficiency was observed in 35% of cases at 15 years after biopsy, and ESRD was found in 23% of cases (Myllimaki et al., 2003) . They also looked for clinical and pathological prognostic factors leading to renal insufficiency or ESRD. In multivariate analysis, hypertension was the only factor that predicted renal insufficiency; on the other hand, none of the multiple factors analyzed was predictive of ESRD. They proposed that this may be due to small number of patients reaching ESRD in their study (Myllimaki et al., 2003) . Another study identified microscopic HU, extent of mesangial proliferation, and global glomerulosclerosis as independent prognostic markers on multivariate analysis (O'Donoghue et al., 1991) . One important complication of IgMN is the transition of the usual mesangial proliferative lesion into the morphologic expression of FSGS. The later is diagnosed only in re-biopsies (Myllimaki et al., 2003; Zeis et al., 2001) .
Conclusion
In conclusion, IgMN is an important cause of renal morbidity in both children and adults in many parts of the world. It shows a spectrum of morphologic changes ranging from minor changes to FSGS. Immunoflourescence is necessary for its diagnosis. Clinically, a poor response to steroid therapy distinguishes this disease from MCD. Further long term longitudinal studies are needed to clarify the status of the disease among the primary glomerulopathies. More studies are also needed to elucidate the etiology and pathogenesis of this disease and develop effective therapeutic regimens.
